Trial Profile
Acute nicotine withdrawal-related cognitive deficits and to investigate the difference between the age groups in treatment-seeking smokers taking varenicline
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 03 Oct 2018 New trial record